BioNTech SE (BNTX)
108.23
+6.09
(+5.96%)
USD |
NASDAQ |
Nov 21, 16:00
107.72
-0.51
(-0.47%)
After-Hours: 06:52
BioNTech Total Liabilities (Quarterly): 3.671B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.671B |
| June 30, 2024 | 3.393B |
| March 31, 2024 | 2.471B |
| December 31, 2023 | 3.051B |
| September 30, 2023 | 2.477B |
| June 30, 2023 | 2.520B |
| March 31, 2023 | 1.978B |
| December 31, 2022 | 3.457B |
| September 30, 2022 | 4.221B |
| June 30, 2022 | 4.518B |
| March 31, 2022 | 4.899B |
| December 31, 2021 | 4.458B |
| Date | Value |
|---|---|
| September 30, 2021 | 6.404B |
| June 30, 2021 | 4.363B |
| March 31, 2021 | 1.975B |
| December 31, 2020 | 1.165B |
| September 30, 2020 | 612.35M |
| June 30, 2020 | 417.83M |
| March 31, 2020 | 313.32M |
| December 31, 2019 | 340.71M |
| September 30, 2019 | 352.30M |
| June 30, 2019 | 384.17M |
| December 31, 2018 | 441.53M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
313.32M
Minimum
Mar 2020
6.404B
Maximum
Sep 2021
2.835B
Average
2.786B
Median
Total Liabilities (Quarterly) Benchmarks
| Novavax Inc | 2.239B |
| DBV Technologies SA | 39.02M |
| Akari Therapeutics PLC | 9.428M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| NuCana PLC | 20.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.02B |
| Shareholders Equity (Quarterly) | 21.35B |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 7.328 |
| Net Debt Paydown Yield | -0.03% |